Literature DB >> 18625311

Human embryonic stem cells: emerging technologies and practical applications.

Lief E Fenno1, Leon M Ptaszek, Chad A Cowan.   

Abstract

Human embryonic stem cells possess the unique ability to differentiate into any adult cell type. Recent advances in the understanding of stem cell biology make new applications possible for stem cell based technology. Of note, it is now possible to reprogram terminally differentiated human somatic cells into pluripotent cells that are functionally equivalent to embryonic stem cells. These induced pluripotent cells may become the substrate for future disease models and cell-based therapies. In addition, novel techniques for genetic manipulation have increased the ease with which genes can be modified into stem cells. In this review, we describe these novel technologies as well as developments in the understanding of basic biology of stem cell pluripotency and differentiation.

Entities:  

Mesh:

Year:  2008        PMID: 18625311     DOI: 10.1016/j.gde.2008.06.004

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  8 in total

Review 1.  Immunogenicity and allogenicity: a challenge of stem cell therapy.

Authors:  Dominique Charron; Caroline Suberbielle-Boissel; Reem Al-Daccak
Journal:  J Cardiovasc Transl Res       Date:  2008-09-26       Impact factor: 4.132

2.  Expansion and characterization of human embryonic stem cell-derived osteoblast-like cells.

Authors:  Premjit Arpornmaeklong; Zhuo Wang; Michael J Pressler; Shelley E Brown; Paul H Krebsbach
Journal:  Cell Reprogram       Date:  2010-08       Impact factor: 1.987

3.  Human embryonic stem cell-derived mesenchymal stem cell seeding on calcium phosphate cement-chitosan-RGD scaffold for bone repair.

Authors:  Wenchuan Chen; Hongzhi Zhou; Michael D Weir; Minghui Tang; Chongyun Bao; Hockin H K Xu
Journal:  Tissue Eng Part A       Date:  2013-01-28       Impact factor: 3.845

4.  Stem cell-based drug therapies: a discussion on emerging technologies and future developments.

Authors:  Jasmine Escalera
Journal:  Yale J Biol Med       Date:  2009-09

5.  Phenotypic characterization, osteoblastic differentiation, and bone regeneration capacity of human embryonic stem cell-derived mesenchymal stem cells.

Authors:  Premjit Arpornmaeklong; Shelley E Brown; Zhuo Wang; Paul H Krebsbach
Journal:  Stem Cells Dev       Date:  2009-09       Impact factor: 3.272

6.  Differentiation of bovine spermatogonial stem cells into osteoblasts.

Authors:  Babak Qasemi-Panahi; Parviz Tajik; Mansoureh Movahedin; Gholamali Moghaddam; Younes Barzgar; Hamed Heidari-Vala
Journal:  Avicenna J Med Biotechnol       Date:  2011-07

7.  Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) engraft in vivo and support hematopoiesis without suppressing immune function: implications for off-the shelf ES-MSC therapies.

Authors:  Ou Li; Ariane Tormin; Berit Sundberg; Johan Hyllner; Katarina Le Blanc; Stefan Scheding
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

8.  Comprehensive in vitro and in vivo studies of novel melt-derived Nb-substituted 45S5 bioglass reveal its enhanced bioactive properties for bone healing.

Authors:  Lucas Souza; João Henrique Lopes; Davi Encarnação; Italo Odone Mazali; Richard Alan Martin; José Angelo Camilli; Celso Aparecido Bertran
Journal:  Sci Rep       Date:  2018-08-24       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.